Kidney cancerMACA CANCER INFORMATION GUIDE

Understanding kidney cancer.

What kidney cancer is, the signs to look out for, how it is diagnosed and staged, and the treatments your care team may discuss with you.

What is kidney cancer?

Kidney cancer begins when cells in the kidney grow out of control and form a tumour. In adults, the most common type is renal cell carcinoma (RCC), which starts in the lining of the tiny tubes (tubules) that filter the blood. About nine in ten kidney cancers are renal cell carcinomas.

How the kidneys work

The kidneys are two bean-shaped organs, each about the size of a fist. They sit against the back wall of the abdomen, one on each side of the spine, protected by the lower ribs. An adrenal gland sits on top of each kidney.

The kidneys filter extra water, salt and waste from the blood to make urine, which travels down tubes called ureters to the bladder. They also make hormones that help control blood pressure and tell the body to produce red blood cells. Most people can live a normal life with one healthy kidney.

How common is kidney cancer?

Around 435,000 people worldwide were diagnosed with kidney cancer in 2022, and about 156,000 died from it. It is almost twice as common in men as in women. Many kidney cancers are now found by chance, on a scan done for another reason, before they cause symptoms.

Signs and symptoms

Early kidney cancer often causes no symptoms. When signs do appear, they can include:

  • Blood in the urine, which may make it look pink, red or cola-coloured
  • A lump or swelling in the side or abdomen
  • Pain in the side or lower back that does not go away and is not caused by an injury
  • Loss of appetite
  • Weight loss without trying
  • Tiredness, often caused by a low red blood cell count (anaemia)
  • A fever that is not caused by an infection

These symptoms are more often caused by other conditions, such as infections or kidney stones, but they should always be checked.

Risk factors

Having a risk factor does not mean you will get kidney cancer, and many people with kidney cancer have no known risk factor. Things that increase the risk include:

  • Smoking: the risk rises with how much a person smokes and falls slowly after quitting.
  • Excess body weight: which causes hormone changes that can lead to renal cell carcinoma.
  • High blood pressure: which is linked to a higher risk.
  • Long-term misuse of some pain medicines: including some sold over the counter.
  • Advanced kidney disease: especially in people who need dialysis.
  • Some workplace chemicals: such as trichloroethylene and cadmium.
  • Family history: particularly if a brother or sister has had kidney cancer.
  • Being male: men are about twice as likely as women to develop renal cell carcinoma.

Inherited conditions

A small number of kidney cancers are linked to inherited conditions, including von Hippel-Lindau disease, hereditary papillary renal carcinoma, hereditary leiomyomatosis and renal cell cancer, Birt-Hogg-Dubé syndrome and tuberous sclerosis. People with these conditions may need regular kidney checks from a young age.

Sickle cell trait and sickle cell disease

Renal medullary carcinoma is a rare, fast-growing kidney cancer that occurs almost only in young people with sickle cell trait or sickle cell disease. Because sickle cell trait is common in Nigeria and across Africa, blood in the urine in a young person with sickle cell trait or disease should always be checked promptly.

Types of kidney cancer

Renal cell carcinoma

Renal cell carcinoma accounts for about nine in ten kidney cancers. It has several subtypes, which can behave and respond to treatment differently:

  • Clear cell RCC: the most common, about seven in ten renal cell carcinomas.
  • Papillary RCC: about one in ten.
  • Chromophobe RCC: about one in twenty.
  • Rare subtypes: including collecting duct carcinoma and renal medullary carcinoma.

Other kidney cancers

  • Urothelial (transitional cell) carcinoma: starts in the renal pelvis, where urine collects before it enters the ureter. It accounts for about 5–10% of kidney cancers and is treated more like bladder cancer.
  • Wilms tumour: almost always occurs in children and is treated differently from adult kidney cancers.
  • Renal sarcoma: a rare cancer that starts in the blood vessels or connective tissue of the kidney.

Not every kidney lump is cancer

Some kidney tumours are benign (not cancer), such as angiomyolipoma and oncocytoma. Scans and sometimes a biopsy help your doctors tell the difference.

Diagnosis

If your doctor thinks you could have kidney cancer, they will ask about your symptoms, health and family history, examine you and arrange tests.

Urine and blood tests

  • Urinalysis: checks the urine for blood and other changes.
  • Blood tests: check your blood count, how well your kidneys and liver are working, and other chemicals in the blood.

Imaging tests

  • Ultrasound scan: often the first test, and useful for telling a solid lump from a fluid-filled cyst.
  • CT scan: the main test for kidney cancer, showing the tumour’s size and whether it has spread.
  • MRI scan: used when more detail is needed, for example about nearby blood vessels.

Biopsy

A biopsy uses a thin needle to take a small sample of the tumour. It is not always needed when scans clearly show kidney cancer, but it can help when the diagnosis is uncertain or before some treatments.

Checking for spread

A CT scan of the chest, a chest X-ray or a bone scan may be used to check whether the cancer has spread.

Stages and outlook

Kidney cancer is staged using the TNM system, which looks at the size of the tumour (T), spread to lymph nodes (N) and spread to other parts of the body (M). These combine into four stages:

  • Stage I: the tumour is 7 cm or smaller and is only in the kidney.
  • Stage II: the tumour is larger than 7 cm and is only in the kidney.
  • Stage III: the cancer has spread to nearby lymph nodes, into large veins such as the renal vein or vena cava, or into the fat around the kidney.
  • Stage IV: the cancer has spread beyond the fatty layer around the kidney, into the adrenal gland, or to distant parts of the body such as the lungs, bones, liver or brain.

Kidney cancer that has spread to another organ is still kidney cancer. Cancer in the lungs that started in the kidney, for example, is treated as kidney cancer.

Outlook

The outlook depends mostly on the stage, the subtype and your general health. Kidney cancer that is found while it is still inside the kidney can often be cured with surgery. Treatments for cancer that has spread have improved greatly in recent years, and many people live well with it for a long time.

Treatment

Your treatment plan depends on the stage and type of cancer, how well your kidneys are working and your general health. It is usually agreed by a team that may include urologists, oncologists and radiologists.

Active surveillance

Small kidney tumours can grow very slowly. For some people, especially older people or those with other health conditions, doctors may suggest monitoring the tumour with regular scans and treating it only if it grows.

Surgery

Surgery is the main treatment for kidney cancer that has not spread.

  • Partial nephrectomy: removes the tumour and some surrounding tissue but keeps the rest of the kidney working. It is often used for smaller tumours.
  • Radical nephrectomy: removes the whole kidney, the fat around it and sometimes the adrenal gland and nearby lymph nodes.

If both kidneys are removed or stop working, dialysis or a kidney transplant is needed.

Ablation and embolisation

Small tumours can sometimes be destroyed without surgery, by freezing them (cryoablation) or heating them (radiofrequency or microwave ablation). Arterial embolisation blocks the blood supply to a tumour, to shrink it or reduce bleeding before surgery.

Radiotherapy

Precise, high-dose radiotherapy (stereotactic ablative radiotherapy) can treat some tumours when surgery is not possible. Radiotherapy is also used to relieve symptoms, such as pain from cancer that has spread to the bones.

Targeted therapy and immunotherapy

For kidney cancer that has spread or is at high risk of coming back, medicines that reach cancer cells throughout the body are used:

  • Targeted therapies: such as sunitinib, pazopanib, cabozantinib and axitinib, block the signals and blood supply that tumours need to grow.
  • Immunotherapies: such as nivolumab, ipilimumab and pembrolizumab, help the immune system find and attack cancer cells.

These medicines are often combined. After surgery, some people at high risk of the cancer coming back are offered pembrolizumab to lower that risk.

Clinical trials

Clinical trials are research studies that test whether a new treatment, a new combination of treatments or a new way of giving an existing treatment works better than current care. Many of today’s standard treatments were first offered through clinical trials.

What taking part involves

  • Every trial has eligibility criteria, such as the type and stage of cancer, previous treatment and general health.
  • Trials must be approved by a research ethics committee and, for medicines, by the national regulator. In Nigeria this includes NAFDAC and a recognised health research ethics committee.
  • You will be given written information and asked for your informed consent before you join. You can ask questions at any time.
  • Taking part is voluntary. You can leave a trial at any point and still receive standard care.

Finding a trial

Your treating team is the best place to start, because they know your diagnosis and which trials could suit you. Trial registries list studies that are recruiting:

  • Pan African Clinical Trials Registry (PACTR): trials taking place in African countries.
  • WHO International Clinical Trials Registry Platform: one search across registries worldwide.
  • ClinicalTrials.gov: a large international registry run by the US National Library of Medicine.

Living with and after treatment

Side effects

Side effects depend on the treatment. After surgery, recovery usually takes a few weeks. Targeted therapies can cause high blood pressure, diarrhoea, tiredness, mouth sores and sore, red skin on the hands and feet. Immunotherapy can cause the immune system to inflame healthy organs, leading to a rash, diarrhoea, breathlessness or changes in thyroid function.

Tell your care team promptly about any new or worsening symptom. Many side effects can be managed, and treatment can be adjusted.

Looking after your kidneys

If you have had a kidney removed or partly removed, your remaining kidney tissue does all the work. Keep your blood pressure under control, drink enough water, avoid medicines that can harm the kidneys (such as regular anti-inflammatory painkillers) unless your doctor agrees, and have your kidney function checked regularly.

Follow-up

Kidney cancer can come back, sometimes many years after treatment, either in the kidney area or elsewhere in the body. You will have regular check-ups and scans for several years so that any change is found early.

Questions to ask your care team

  • What type of kidney cancer do I have, and what stage is it?
  • Is the tumour small enough to monitor, or to remove while keeping part of my kidney?
  • What are my treatment options, and what is the aim of each one?
  • How will treatment affect my kidney function?
  • What side effects should I expect, and who do I contact if I have them?
  • Is there a clinical trial that could be right for me?
  • How often will I need follow-up scans?

LET’S KEEP THE CONVERSATION GOING

Understanding grows
when we come together.

Connect with MACA